4045 東亞合成

時価

1803億円

PER 予

15.49倍

2009年以降

6.17-27.13倍
（2009-2023年）

0.83倍

2009年以降

0.51-1.14倍
（2009-2023年）

3.77%

ROE 予

5.36%

ROA 予

4.16%

Assets - Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activities Member、Laboratory Transfer ExpensesNOE、売上高 - 基幹化学品事業

【期間】

年度	Assets - Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activities Member		Laboratory Transfer ExpensesNOE		売上高 - 基幹化学品事業
2013/03	-		-		111億
2014/03	-		-		109億	-2.3%
2015/03	-		-		108億	-1%
2016/03	-		-		105億	-2.5%
2017/03	-		-		173億	+64.7%
2018/03	-		-		185億	+6.8%
2019/03	-		-		169億	-8.7%
2020/03	-		-		162億	-3.8%
2021/03	-		-		165億	+1.7%
2022/03	-		-		174億	+5.2%
2023/03	-		-		184億	+5.7%
2024/03	-		-		188億	+2.6%

2013年3月

Assets - Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activities Member: -
Laboratory Transfer ExpensesNOE: -
売上高 - 基幹化学品事業: 111億4400万

2014年3月

Assets - Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activities Member: -
Laboratory Transfer ExpensesNOE: -
売上高 - 基幹化学品事業: 108億9100万

2015年3月

Assets - Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activities Member: -
Laboratory Transfer ExpensesNOE: -
売上高 - 基幹化学品事業: 107億7900万

2016年3月

Assets - Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activities Member: -
Laboratory Transfer ExpensesNOE: -
売上高 - 基幹化学品事業: 105億700万

2017年3月

Assets - Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activities Member: -
Laboratory Transfer ExpensesNOE: -
売上高 - 基幹化学品事業: 173億600万

2018年3月

Assets - Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activities Member: -
Laboratory Transfer ExpensesNOE: -
売上高 - 基幹化学品事業: 184億8700万

2019年3月

Assets - Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activities Member: -
Laboratory Transfer ExpensesNOE: -
売上高 - 基幹化学品事業: 168億8000万

2020年3月

Assets - Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activities Member: -
Laboratory Transfer ExpensesNOE: -
売上高 - 基幹化学品事業: 162億3800万

2021年3月

Assets - Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activities Member: -
Laboratory Transfer ExpensesNOE: -
売上高 - 基幹化学品事業: 165億2100万

2022年3月

Assets - Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activities Member: -
Laboratory Transfer ExpensesNOE: -
売上高 - 基幹化学品事業: 173億7500万

2023年3月

Assets - Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activities Member: -
Laboratory Transfer ExpensesNOE: -
売上高 - 基幹化学品事業: 183億6000万

2024年3月

Assets - Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activities Member: -
Laboratory Transfer ExpensesNOE: -
売上高 - 基幹化学品事業: 188億2900万